FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Khalil

Research Profile

Disorders

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Simone Mader; Andreas Lutterotti; Franziska Di Pauli; Bettina Kuenz; Kathrin Schanda; Fahmy Aboul-Enein; Michael Khalil; Maria K Storch; Sven Jarius; Wolfgang Kristoferitsch; Thomas Berger; Markus Reindl
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
Claudia Gneiss; P Tripp; F Reichartseder; Robert Egg; Rainer Ehling; Andreas Lutterotti; Michael Khalil; Bettina Kuenz; Irmgard Mayringer; Markus Reindl; Thomas Berger; Florian Deisenhammer
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.
Andreas Lutterotti; Bettina Kuenz; Viktoria Gredler; Michael Khalil; Rainer Ehling; Claudia Gneiss; Robert Egg; Florian Deisenhammer; Thomas Berger; Markus Reindl
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Khalil (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Simone Mader; Andreas Lutterotti; Franziska Di Pauli; Bettina Kuenz; Kathrin Schanda; Fahmy Aboul-Enein; Michael Khalil; Maria K Storch; Sven Jarius; Wolfgang Kristoferitsch; Thomas Berger; Markus Reindl
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
PloS one 2010;5(5):e10455.
2006: Claudia Gneiss; P Tripp; F Reichartseder; Robert Egg; Rainer Ehling; Andreas Lutterotti; Michael Khalil; Bettina Kuenz; Irmgard Mayringer; Markus Reindl; Thomas Berger; Florian Deisenhammer
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(6):731-7.
2006: Andreas Lutterotti; Bettina Kuenz; Viktoria Gredler; Michael Khalil; Rainer Ehling; Claudia Gneiss; Robert Egg; Florian Deisenhammer; Thomas Berger; Markus Reindl
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Journal of neuroimmunology 2006;181(1-2):145-9.
2006: Markus Reindl; Michael Khalil; Thomas Berger
Antibodies as biological markers for pathophysiological processes in MS.
Journal of neuroimmunology 2006;180(1-2):50-62.
2006: Claudia Gneiss; P Tripp; Rainer Ehling; Michael Khalil; Andreas Lutterotti; Robert Egg; Irmgard Mayringer; B Künz; Thomas Berger; Markus Reindl; Florian Deisenhammer
Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
Journal of neuroimmunology 2006;174(1-2):174-9.
2006: Michael Khalil; Markus Reindl; Andreas Lutterotti; Bettina Kuenz; Rainer Ehling; Claudia Gneiss; Peter Lackner; Florian Deisenhammer; Thomas Berger
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
Journal of neuroimmunology 2006;174(1-2):147-56.
2005: Bettina Kuenz; Andreas Lutterotti; Michael Khalil; Rainer Ehling; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
Journal of neuroimmunology 2005;167(1-2):143-9.
2004: Rainer Ehling; Andreas Lutterotti; Julia Wanschitz; Michael Khalil; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(6):601-6.
2004: Claudia Gneiss; Markus Reindl; Andreas Lutterotti; Rainer Ehling; Robert Egg; Michael Khalil; Thomas Berger; Florian Deisenhammer
Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(5):507-10.